Secondary primary malignancies in thyroid cancer survivors treated by radioiodine I-131. Is it really linked with radioiodine therapy? an experience in a single center

Kunihiro Nakada

Presentation information

[WFNMB]Poster

The13th Congress of the World Federation of Nuclear Medicine and Biology(WFNMB2022) » [WFNMB]Poster Program

Endocrinology2

Others

Sun. Sep 11, 2022 8:00 AM - 8:00 PM Web distribution only (配信のみ)

[WP-5-1] Secondary primary malignancies in thyroid cancer survivors treated by radioiodine I-131. Is it really linked with radioiodine therapy? an experience in a single center

Kunihiro Nakada¹、Arinori Yoshida²、Hiroki Sugie²、Yasushi Furuta³、Masayuki Sakurai¹ (1.Hokko Memorial Hospial、2.LSI Sapporo Clinic、3.Teine Keijinkai Hospital)

Abstract password authentication.The password is described on page 8 of the "WFNMB2022 Program"

« Previous in this session
Next in this session »

▲

Presentation information

Endocrinology2

Others

[WP-5-1] Secondary primary malignancies in thyroid cancer survivors treated by radioiodine I-131. Is it really linked with radioiodine therapy? an experience in a single center

Password